Can You Fall Pregnant on Mounjaro — and Is It Safe?

Why pregnancy is possible, and unplanned pregnancies do happen on GLP-1 treatment

Mounjaro works by activating two gut-hormone receptors, slowing gastric emptying and reducing appetite. One consequence of meaningful weight loss is hormonal change: in women with conditions that suppressed ovulation (polycystic ovary syndrome being the most common) regular cycles can return as body weight falls. Falling pregnant on Mounjaro is therefore more likely than many people expect, particularly if a woman previously believed she had low fertility.

This is not a theoretical risk. NHS guidance specifically flags it, and clinicians prescribing GLP-1 medicines are advised to raise it at consultation. The important message is not to panic if it happens, but to stop treatment and contact a healthcare professional promptly.

There is also a practical oral contraceptive issue. Mounjaro slows gastric emptying, which can reduce how much of a daily pill is absorbed, and this effect is most pronounced in the first four weeks of a new dose. NHS Scotland's guidance on GLP-1 medicines, verified by the NHS Inform page on diabetes and weight-loss medication, states that women using the pill should use an additional non-oral method for the first four weeks of starting tirzepatide and for four weeks after every dose increase. Semaglutide (Wegovy) does not carry an equivalent instruction, because the evidence for reduced pill absorption is specific to tirzepatide. Worth checking with your GP or prescriber if you are unsure which method applies to you.

What current guidance says about Mounjaro and an established pregnancy

There are no adequate, well-controlled clinical studies of tirzepatide in human pregnancies. Animal studies showed adverse effects at doses producing exposures similar to the therapeutic range, which is why the precautionary position is clear: Mounjaro should not be used during pregnancy. The NHS medicines page for tirzepatide and the full Summary of Product Characteristics both state this explicitly.

If you discover you are pregnant while taking Mounjaro, stop treatment and speak to your midwife, GP or obstetrician as soon as possible. Stopping quickly is the right call, the available evidence does not support continuing. Your team will discuss ongoing monitoring and any next steps.

Breastfeeding is also an exclusion: tirzepatide is not recommended while breastfeeding, because it is not known whether the medicine passes into breast milk or what effect it might have on a nursing infant. Again, the decision on timing around breastfeeding should be made with a prescriber, not on the basis of general content. For more on the questions that come up once a pregnancy is confirmed, the information on Mounjaro and being pregnant covers the detail.

Contraception, timing and when to stop, the practical picture

The MHRA advises that effective contraception should be used throughout Mounjaro treatment. A wash-out period before actively trying to conceive is also recommended, though the precise duration should be confirmed by your prescriber based on your specific situation, rather than drawn from general guidance online.

If your current contraception is oral-only (the combined pill or progesterone-only pill) the four-week additional non-oral method rule at each dose step is not something to skip. Questions about contraception and getting pregnant on Mounjaro come up regularly in consultations; it is one of the most common practical queries our prescribers field.

NHS England's guidance on weight-management injections, published on the NHS England obesity medicines pages, also advises women using tirzepatide who are on HRT to discuss transdermal options (patches or gels) with their doctor, as the absorption concern applies there too.

For anyone who became pregnant while already on treatment and is trying to understand what happened next for others, the account of what to do if you got pregnant on Mounjaro covers the recommended steps clearly. The short version: stop the medicine, contact your maternity team, and let your prescriber know. It is also worth being aware that our guidance on tirzepatide and acute kidney injury explains why staying well hydrated matters particularly during any period of illness or rapid change in your condition, including early pregnancy.

What to do if you have questions before starting or continuing treatment

Mounjaro is a prescription-only medicine. That means a registered prescriber reviews your full medical picture before anything is dispensed, not a questionnaire algorithm, but a real clinician. At our GPhC-registered pharmacy, that review happens the same day.

If you are in any doubt about contraception, fertility, cycle changes or what stopping treatment looks like, those questions belong in your consultation. You can also raise them with your GP. For safety-relevant interactions (alcohol, other medicines, travel) the general FAQs cover common ground, and our team is available seven days a week for aftercare queries once you are on treatment.

If you are not yet on treatment and want to understand the full picture first, the overview of weight-loss treatments available through nume is a good starting point, and a free consultation means a prescriber can address the pregnancy and contraception questions as part of your assessment, not as an afterthought.